Shengyang He1, Wenlong Liu2, Mingyan Jiang3, Peng Huang4, Zhi Xiang5, Dingding Deng6, Ping Chen7, Lihua Xie1. 1. Department of Respiratory and Critical Care Medicine, The Third Xiangya Hospital of Central South University, Hunan, China. 2. Department of Respiratory and Critical Care Medicine, The Second People Hospital of Yueyang, Yueyang, China. 3. Department of Respiratory and Critical Medicine, Xiangtan Central Hospital, Xiangtan, China. 4. Department of Respiratory and Critical Medicine, The Zhuzhou Central Hospital, Zhuzhou, China. 5. Department of Respiratory and Critical Medicine, The First People Hospital of Huaihua, Huaihua, China. 6. Department of Respiratory and Critical Medicine, The First People Hospital of Shaoyang, Shaoyang, China. 7. Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital of Central South University, Hunan, China.
Abstract
OBJECTIVE: To understand the clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection (CDBC), and therefore contributing to their early identification and prognosis estimation. METHOD: 905 COVID-19 patients from 7 different centers were enrolled. The demography data, clinical manifestations, laboratory results, and treatments were collected accordingly for further analyses. RESULTS: Around 9.5% of the enrolled COVID-19 patients were diagnosed with CDBC. Older patients or patients with cardiovascular comorbidities have increased CDBC probability. Increased body temperature, longer fever duration, anhelation, gastrointestinal symptoms, illness severity, intensive care unit attending, ventilation treatment, glucocorticoid therapy, longer hospitalization time are correlated to CDBC. Among laboratory results, increased white blood cell counting (mainly neutrophil), lymphocytopenia, increased procalcitonin, erythrocyte sedimentation rate, C-reaction protein, D-dimer, blood urea nitrogen, lactate dehydrogenase, brain natriuretic peptide, myoglobin, blood sugar and decreased albumin are also observed, indicating multiple system functional damage. Radiology results suggested ground glass opacity mixed with high density effusion opacities and even pleural effusion. CONCLUSION: The aged COVID-19 patients with increased inflammatory indicators, worse lymphopenia and cardiovascular comorbidities are more likely to have clinically diagnosed bacterial co-infection. Moreover, they tend to have severer clinical manifestations and increased probability of multiple system functional damage.
OBJECTIVE: To understand the clinical characteristics of COVID-19patients with clinically diagnosed bacterial co-infection (CDBC), and therefore contributing to their early identification and prognosis estimation. METHOD: 905 COVID-19patients from 7 different centers were enrolled. The demography data, clinical manifestations, laboratory results, and treatments were collected accordingly for further analyses. RESULTS: Around 9.5% of the enrolled COVID-19patients were diagnosed with CDBC. Older patients or patients with cardiovascular comorbidities have increased CDBC probability. Increased body temperature, longer fever duration, anhelation, gastrointestinal symptoms, illness severity, intensive care unit attending, ventilation treatment, glucocorticoid therapy, longer hospitalization time are correlated to CDBC. Among laboratory results, increased white blood cell counting (mainly neutrophil), lymphocytopenia, increased procalcitonin, erythrocyte sedimentation rate, C-reaction protein, D-dimer, blood ureanitrogen, lactate dehydrogenase, brain natriuretic peptide, myoglobin, blood sugar and decreased albumin are also observed, indicating multiple system functional damage. Radiology results suggested ground glass opacity mixed with high density effusion opacities and even pleural effusion. CONCLUSION: The aged COVID-19patients with increased inflammatory indicators, worse lymphopenia and cardiovascular comorbidities are more likely to have clinically diagnosed bacterial co-infection. Moreover, they tend to have severer clinical manifestations and increased probability of multiple system functional damage.
Authors: Cybele L Abad; Joanne Carmela M Sandejas; Jonnel B Poblete; Anna Flor G Malundo; Maria Sonia S Salamat; Marissa M Alejandria Journal: IJID Reg Date: 2022-07-08
Authors: Abdulaziz Alqahtani; Edrous Alamer; Mushtaq Mir; Ali Alasmari; Mohammed Merae Alshahrani; Mohammed Asiri; Irfan Ahmad; Abdulaziz Alhazmi; Abdullah Algaissi Journal: Int J Environ Res Public Health Date: 2022-02-19 Impact factor: 3.390
Authors: Omary Mzava; Alexandre Pellan Cheng; Adrienne Chang; Sami Smalling; Liz-Audrey Djomnang Kounatse; Joan Lenz; Randy Longman; Amy Steadman; Mirella Salvatore; Manikkam Suthanthiran; John R Lee; Christopher E Mason; Darshana Dadhania; Iwijn De Vlaminck Journal: bioRxiv Date: 2021-11-23
Authors: S Soltani; S Faramarzi; M Zandi; R Shahbahrami; A Jafarpour; S Akhavan Rezayat; I Pakzad; F Abdi; P Malekifar; R Pakzad Journal: New Microbes New Infect Date: 2021-07-01